172 related articles for article (PubMed ID: 29600921)
1. [Hospital of diagnosis influences the probability of receiving curative treatment for oesophageal and gastric cancer].
van Putten M; Verhoeven RHA; Koëter M; van Laarhoven HWM; van Sandick JW; Plukker JTM; Siersema PD; Hulshof MCCM; Wijnhoven BPL; Lemmens VEPP; Nieuwenhuijzen GAP
Ned Tijdschr Geneeskd; 2018; 162():D1970. PubMed ID: 29600921
[TBL] [Abstract][Full Text] [Related]
2. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
van Putten M; Koëter M; van Laarhoven HWM; Lemmens VEPP; Siersema PD; Hulshof MCCM; Verhoeven RHA; Nieuwenhuijzen GAP
Ann Surg; 2018 Feb; 267(2):303-310. PubMed ID: 27811508
[TBL] [Abstract][Full Text] [Related]
3. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer.
Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Wijnhoven BP; Nieuwenhuijzen GA
Eur J Surg Oncol; 2014 Oct; 40(10):1338-45. PubMed ID: 24484779
[TBL] [Abstract][Full Text] [Related]
4. Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer.
van Putten M; Verhoeven RH; van Sandick JW; Plukker JT; Lemmens VE; Wijnhoven BP; Nieuwenhuijzen GA
Br J Surg; 2016 Feb; 103(3):233-41. PubMed ID: 26621158
[TBL] [Abstract][Full Text] [Related]
5. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
[TBL] [Abstract][Full Text] [Related]
6. Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.
Luijten JCHBM; Vissers PAJ; Geerts J; Lemmens VEP; van Hillegersberg R; Beerepoot L; Walraven JEW; Curvers W; Voncken FEM; van der Sangen M; Verhoeven RHA; Nieuwenhuijzen GAP
Eur J Surg Oncol; 2023 Sep; 49(9):106880. PubMed ID: 37055281
[TBL] [Abstract][Full Text] [Related]
7. Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based study.
Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Nieuwenhuijzen GA
Cancer Epidemiol; 2015 Dec; 39(6):863-9. PubMed ID: 26651448
[TBL] [Abstract][Full Text] [Related]
8. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008.
Coupland VH; Lagergren J; Lüchtenborg M; Jack RH; Allum W; Holmberg L; Hanna GB; Pearce N; Møller H
Gut; 2013 Jul; 62(7):961-6. PubMed ID: 23086798
[TBL] [Abstract][Full Text] [Related]
9. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
[TBL] [Abstract][Full Text] [Related]
10. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009.
Dikken JL; Dassen AE; Lemmens VE; Putter H; Krijnen P; van der Geest L; Bosscha K; Verheij M; van de Velde CJ; Wouters MW
Eur J Cancer; 2012 May; 48(7):1004-13. PubMed ID: 22456179
[TBL] [Abstract][Full Text] [Related]
11. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection.
Güller U; Warschkow R; Ackermann CJ; Schmied B; Cerny T; Ess S
Swiss Med Wkly; 2017; 147():w14473. PubMed ID: 28750418
[TBL] [Abstract][Full Text] [Related]
12. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery.
Dikken JL; Wouters MW; Lemmens VE; Putter H; van der Geest LG; Verheij M; Cats A; van Sandick JW; van de Velde CJ
Br J Surg; 2012 Jul; 99(7):954-63. PubMed ID: 22569956
[TBL] [Abstract][Full Text] [Related]
13. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.
Haj Mohammad N; Bernards N; van Putten M; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
Eur J Cancer; 2017 Jun; 78():28-36. PubMed ID: 28412586
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a regional video multidisciplinary team meeting is associated with an improved prognosis for patients with oesophageal cancer A mixed methods approach.
Luijten JCHBM; Haagsman VC; Luyer MDP; Vissers PAJ; Nederend J; Huysentruyt C; Creemers GJ; Curvers W; van der Sangen M; Heesakkers FBM; Schrauwen RWM; Jürgens MC; Buster EHCJ; Vincent J; Kneppelhout JK; Verhoeven RHA; Nieuwenhuijzen GAP
Eur J Surg Oncol; 2021 Dec; 47(12):3088-3096. PubMed ID: 33926781
[TBL] [Abstract][Full Text] [Related]
15. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
[TBL] [Abstract][Full Text] [Related]
16. Presentation, Treatment, and Prognosis of Esophageal Carcinoma in a Nationwide Comparison of Sweden and the Netherlands.
Kalff MC; Gottlieb-Vedi E; Verhoeven RHA; van Laarhoven HWM; Lagergren J; Gisbertz SS; Markar SR; van Berge Henegouwen MI
Ann Surg; 2021 Nov; 274(5):743-750. PubMed ID: 34353984
[TBL] [Abstract][Full Text] [Related]
17. Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.
Trip AK; Stiekema J; Visser O; Dikken JL; Cats A; Boot H; van Sandick JW; Jansen EP; Verheij M
Acta Oncol; 2015 Nov; 54(10):1754-62. PubMed ID: 25797568
[TBL] [Abstract][Full Text] [Related]
18. SOURCE: Prediction Models for Overall Survival in Patients With Metastatic and Potentially Curable Esophageal and Gastric Cancer.
van den Boorn HG; Abu-Hanna A; Haj Mohammad N; Hulshof MCCM; Gisbertz SS; Klarenbeek BR; Slingerland M; Beerepoot LV; Rozema T; Sprangers MAG; Verhoeven RHA; van Oijen MGH; Zwinderman KH; van Laarhoven HWM
J Natl Compr Canc Netw; 2021 Apr; 19(4):403-410. PubMed ID: 33636694
[TBL] [Abstract][Full Text] [Related]
19. Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.
Luijten JCHBM; Vissers PAJ; Brom L; de Bièvre M; Buijsen J; Rozema T; Mohammad NH; van Duijvendijk P; Kouwenhoven EA; Eshuis WJ; Rosman C; Siersema PD; van Laarhoven HWM; Verhoeven RHA; Nieuwenhuijzen GAP; Westerman MJ
BMC Health Serv Res; 2022 Apr; 22(1):527. PubMed ID: 35449018
[TBL] [Abstract][Full Text] [Related]
20. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
Busweiler LA; Henneman D; Dikken JL; Fiocco M; van Berge Henegouwen MI; Wijnhoven BP; van Hillegersberg R; Rosman C; Wouters MW; van Sandick JW;
Eur J Surg Oncol; 2017 Oct; 43(10):1962-1969. PubMed ID: 28797755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
